Roehrl_Lab

Physician, scientist, pathologist, cancer researcher, mass spec aficionado, proteomics man, hobby chef, and outdoors guy

[Roehrl_Lab @Roehrl_Lab]

Please apply! Postdoctoral Positions (#Roehrl_Lab) at BIDMC/Harvard (Boston): Cancer Multi-Omics and/or Autoimmunity #HMS #BIDMC https://t.co/8AZw6ERArx

[Roehrl_Lab @Roehrl_Lab]

New paper on CRC with participation of the #Roehrl_Lab Colorectal Adenoma Subtypes Exhibit Signature Molecular Profiles: Unique Insights into the Microenvironment of Advanced Precancerous Lesions for Early Detection Applications https://t.co/NvS5R7Gp0J

[Roehrl_Lab @Roehrl_Lab]

New paper from #Roehrl_Lab #HMS #BIDMC C1orf50 Accelerates Epithelial-Mesenchymal Transition and the Cell Cycle of Hepatocellular Carcinoma | Cancer Genomics & Proteomics https://t.co/TzNwbMVMfD

[Roehrl_Lab @Roehrl_Lab]

#Roehrl_Lab Best Clinical Science Paper 2024 Award for Dr. Atsushi Tanaka (Roehrl Lab at #BIDMC #HMS) for our colon cancer proteogenomics paper in Cell Reports!

[BIDMC Cancer Center @BIDMC_CancerCtr]

🏆Our Cancer Research Institute proudly recognizes the “Best Papers of 2024”! ⭐️Atsushi Tanaka, MD, PhD
⭐️Giulia Cheloni, PhD, and Dimitra Karagkouni, PhD
⭐️Alex Toker, PhD
⭐️Antoine Karnoub, PhD
We celebrate their outstanding work in driving discovery forward!
#CancerResearch

[Roehrl_Lab @Roehrl_Lab]

#Roehrl_Lab Melanoma Paper #HMS #BIDMC C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness | Cancer Genomics & Proteomics https://t.co/XdsbzA4jfA

[Roehrl_Lab @Roehrl_Lab]

#Roehrl_Lab Breast Cancer Paper #HMS #BIDMC The role of C1orf50 in breast cancer progression and prognosis | Breast Cancer https://t.co/KXNoyJQsH8

[Roehrl_Lab @Roehrl_Lab]

The 2024 Report on the Human Proteome from the HUPO Human Proteome Project | Journal of Proteome Research https://t.co/B7mbMcRzfv

[Roehrl_Lab @Roehrl_Lab]

New #proteomics paper from the #Roehrl_Lab #BIDMC #HMS https://t.co/mCWSuihkHe

[Roehrl_Lab @Roehrl_Lab]

Our new neuroendocrine tumor
proteomics paper #Roehrl_Lab #BIDMC #HMS #Neuroendocrine #NETRF https://t.co/G7OqBl89jz

[Roehrl_Lab @Roehrl_Lab]

Newest paper from the #Roehrl_Lab at #BIDMC and #HMS #Harvard on pancreatic neuroendocrine tumors #NET #Proteomics https://t.co/t0dPSmqUav

[Roehrl_Lab @Roehrl_Lab]

New #cancer #biomarker paper in #PLOSONE from the #Roehrl_Lab at #BIDMC #HMS https://t.co/HlfZf0kF9P

[Roehrl_Lab @Roehrl_Lab]

Exciting new paper from the #Roehrl_Lab in #PLOS_ONE on a smart computational strategy for better identifying "needles-in-a-haystack" biomarkers: Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis https://t.co/i77ZYHRYj6

[Roehrl_Lab @Roehrl_Lab]

New paper from the #Roehrl_Lab at #BIDMC and #HMS

Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures: Cell Reports https://t.co/6bwsVtux54

[Roehrl_Lab @Roehrl_Lab]

And another one back-to-back from our team:
An autoantigen profile from Jurkat T-Lymphoblasts provides a molecular guide for investigating autoimmune sequelae of COVID-19 https://t.co/r9UKb8fMHF

[Roehrl_Lab @Roehrl_Lab]

New paper from our team!
An autoantigen-ome from HS-Sultan B-Lymphoblasts offers a molecular map for investigating autoimmune sequelae of COVID-19 https://t.co/Zal3qHElsH

[BIDMC Pathology @BIDMCpath]

⚜️ Wishing a warm welcome (pun intended, 🌞☀️) to our new residents ! ⚜️

We're so excited to see you progress through this amazing journey!

#pathology #path2path #pathmatch

[BIDMC Pathology @BIDMCpath]

🔰We are happy to announce the start of our Undergrad observership program🔰

Four students that are underrepresented in medicine will participate.

📷Two students at GI path conference with @Vik_deshpandeMD, @Mvgs1706 , @YuhoMD and @MasaPericMD. Thanks GI team!
#URiM #pathology

[BIDMC Pathology @BIDMCpath]

🗣️📢 Attention #pathtwitter verse and #pathmatch / #path2path applicants

We will have a Virtual Open House for our Residency Program August 22nd

Stay tuned for a registration link!

[BIDMC Pathology @BIDMCpath]

🔸🔶 Welcome our new residents! 🔶🔸

We are looking forward to going on this great adventure with you 🙏

#pathology #path2path #path2023 #Match2023